8 Analysts Assess Allstate: What You Need To Know
Portfolio Pulse from Benzinga Insights
Allstate (NYSE:ALL) has been reviewed by 8 analysts, showing a shift towards more positive ratings over the past three months. The average 12-month price target is now $149.38, up 8.14% from the previous $138.14. Analysts from firms like HSBC, BMO Capital, UBS, Goldman Sachs, Raymond James, Piper Sandler, Roth MKM, and Citigroup have raised their price targets, indicating a bullish outlook. Allstate's financial performance shows a revenue growth of 9.76% but lags in net margin, ROE, and ROA, with a high debt-to-equity ratio of 0.63.
December 28, 2023 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Allstate has received increasingly positive analyst ratings, with an average 12-month price target raised to $149.38. Financial indicators show growth but also highlight profitability and debt management challenges.
The positive shift in analyst ratings and raised price targets suggest a bullish sentiment, which could lead to a short-term increase in stock price. However, the financial challenges noted may temper the stock's performance, hence the score is not at the maximum bullish level.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100